Literature DB >> 25618424

Immunosuppressive therapy and cancer risk in ocular inflammation patients: fresh evidence and more questions.

Naira Khachatryan1, John H Kempen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25618424     DOI: 10.1016/j.ophtha.2014.11.023

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  3 in total

Review 1.  Immunosuppression for the Uveitides.

Authors:  Douglas A Jabs
Journal:  Ophthalmology       Date:  2017-09-20       Impact factor: 12.079

2.  Blueberries inhibit cyclooxygenase-1 and cyclooxygenase-2 activity in human epithelial ovarian cancer.

Authors:  Wumei Lin; Zhigang Li
Journal:  Oncol Lett       Date:  2017-04-25       Impact factor: 2.967

3.  Using a patient-centered approach to benefit-harm assessment in treatment decision-making: a case study in uveitis.

Authors:  Tsung Yu; Janet T Holbrook; Jennifer E Thorne; Milo A Puhan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-01-22       Impact factor: 2.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.